NASDAQ:CBIO

Catalyst Biosciences Stock Predictions

> Biotechnology

Buy CBIO

*Your capital is at risk

$17.98

+0.98 (+5.73%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CBIO Prediction Chart

CBIO Predictions History

Latest community submissions for CBIO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
not me	Jun 5, 2017	$2.58 -38.13%	$4.17	X	61.90%
JS Pro	Apr 7, 2017	$7.38 +35.41%	$5.45	X	64.60%
JS Pro	Dec 29, 2016	$0.686 +3.84%	$0.660	V	96.10%
AJR	Dec 19, 2016	$0.790 +8.70%	$0.730	X	91.80%
JS Pro	Dec 19, 2016	$0.80 +10.35%	$0.730	X	90.10%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CBIO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CATALYST BIOSCIENCES INC

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by